G 13 7 (Oxcarbazepine 150 mg)

Pill imprint G 13 7 has been identified as Oxcarbazepine 150 mg.

Oxcarbazepine is used in the treatment of seizures; bipolar disorder; anxiety; trigeminal neuralgia; cyclothymic disorder and belongs to the drug class dibenzazepine anticonvulsants. Risk cannot be ruled out during pregnancy. Oxcarbazepine 150 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for G 13 7

Oxcarbazepine 150 mg G 13 7 Front
Oxcarbazepine 150 mg G 13 7 Back
Oxcarbazepine 150 mg G 13 7
Oxcarbazepine 150 mg G 13 7
Oxcarbazepine 150 mg G 13 7
Oxcarbazepine
Imprint:
G
13 7
Strength:
150 mg
Color:
Yellow
Size:
11.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Dibenzazepine anticonvulsants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Glenmark Generics Inc.
National Drug Code (NDC):
68462-0137
Inactive Ingredients:
silicon dioxide
crospovidone
ferric oxide yellow
hypromelloses
magnesium stearate
meglumine
microcrystalline cellulose
polyethylene glycol
titanium dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
33261-0684 Aidarex Pharmacuticals LLC (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web3)